Mediford Corporation is a premier Japanese contract research organization (CRO) specializing in preclinical and clinical bioanalysis, safety evaluation, and biomarker testing. Operating under strict GLP guidelines, Mediford provides the pharmaceutical industry with high-quality analytical services, pharmacokinetic evaluations, and regulatory-grade data to support global drug submissions.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.